Lot Consistency Study of COVID-19 and Influenza Combination Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP
- Status
- COMPLETED
- Phase
- PHASE1
Dime La VerDAD: Verify, Debunk, and Disseminate
- Status
- RECRUITING
- Phase
- NA
A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
- Status
- COMPLETED
- Phase
- PHASE1
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities
- Status
- TERMINATED
- Phase
- NA
Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.
- Status
- RECRUITING
- Phase
- NA
The Role of Cxcr4Hi neutrOPhils in InflueNza
- Status
- RECRUITING
- Phase
- N/A
Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)
- Status
- COMPLETED
- Phase
- PHASE4
Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI
- Status
- COMPLETED
- Phase
- NA
The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Evaluation of a Screen and Treat Protocol for Influenza
- Status
- TERMINATED
- Phase
- N/A
Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
- Status
- COMPLETED
- Phase
- PHASE3
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
- Status
- RECRUITING
- Phase
- N/A
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.
- Status
- WITHDRAWN
- Phase
- N/A
Xofluza-Wearables Feasibility-Study
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
- Status
- RECRUITING
- Phase
- N/A